As shown in previous studies, S1P either directly transactivated EGF receptors (EGFR) in gastric cancer cells or was responsible for upregulating EGFR in lung or breast cancer cells, contributing to tumour progression [62,63,64]. Here, EGFR is linked to breast cancer.